Hemenway Trust Hemenway Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-11,295
Closed -$1.12M 135
2019
Q3
$1.12M Sell
11,295
-4,140
-27% -$393K 0.18% 64
2019
Q2
$1.43M Sell
15,435
-4,845
-24% -$460K 0.22% 59
2019
Q1
$1.91M Sell
20,280
-411
-2% -$35.9K 0.31% 51
2018
Q4
$1.33M Sell
20,691
-61,845
-75% -$4.57M 0.27% 54
2018
Q3
$7.39M Buy
82,536
+12,830
+18% +$1.13M 1.24% 29
2018
Q2
$5.54M Buy
69,706
+21,836
+46% +$1.81M 1.02% 32
2018
Q1
$4.27M Buy
47,870
+14,360
+43% +$1.38M 0.81% 38
2017
Q4
$3.5M Buy
+33,510
New +$3.78M 0.67% 40

Other funds holding CELG

Hemenway Trust Hemenway Trust's CELG Position: Q4 2019 in Review

Hemenway Trust Hemenway Trust sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 11,295 shares — an estimated $1.12M sold.

Hemenway Trust Hemenway Trust first reported a position in CELG in Q4 2017 and held it in 8 quarters. The position peaked at $7.39M in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Hemenway Trust Hemenway Trust reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Hemenway Trust Hemenway Trust sold 11,295 Celgene Corp shares in Q4 2019, an estimated $1.12M.
  • Hemenway Trust Hemenway Trust first reported a position in Celgene Corp in Q4 2017 and held it in 8 quarters.
  • Hemenway Trust Hemenway Trust's Celgene Corp position peaked at $7.39M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Hemenway Trust Hemenway Trust's 13F filing for Q4 2019, filed 15 Jan 2020.